Novonesis (Novozymes) B (OTCPK:NVZMF)
$ 60.875 1.133 (1.9%) Market Cap: 28.48 Bil Enterprise Value: 30.18 Bil PE Ratio: 38.65 PB Ratio: 2.42 GF Score: 97/100

Novozymes A/S Capital Markets Day (Virtual) Transcript

Sep 28, 2021 / 11:00AM GMT
Release Date Price: $70.47 (+1.75%)
Tobias Cornelius Bjorklund;S;Head of IR
Novozymes A

/-

Good afternoon, everyone, and welcome here from Denmark to Novozymes's fully virtual and live Capital Markets Day 2021. My name is Tobias Bjorklund, and I'm the Head of Investor Relations. On behalf of all of us, I'd like to thank you for joining us here today. We are very much looking forward to share Novozymes' strategic priorities and ambitions with you here today. Shifting to the next slide here, you can see the program for the day. We have the full management team available and the session will last for approximately 2.5 hours.

Apart from the presenters, that you see here on the agenda. We are also joined by 2 additional executive members. They are Graziela Malucelli, Executive Vice President, Operations, Supply and Quality, and Morten Rasmussen, who is our Executive Vice President, People Sustainability and Brand. Let me briefly go through a few of the practicalities for the next 2.5 hours. We have 2 Q&A sessions.

And the lines for those will open roughly 30 minutes prior to each of those

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot